A Chronic-Dose Safety and Efficacy Study of Albuterol Multi-Dose Dry Powder Inhaler in Pediatric Asthmatics
Public ClinicalTrials.gov record NCT02126839. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Three-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Chronic-Dose Safety and Efficacy Study of Albuterol Multi-Dose Dry Powder Inhaler (MDPI) Relative to Placebo in Pediatric Asthmatics
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study is to evaluate the chronic-dose efficacy and the safety of Albuterol MDPI compared to placebo in pediatric participants with asthma.
Study identification
- NCT ID
- NCT02126839
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 186 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 4 Years to 11 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2014 (Type not available)
- Primary completion
- Feb 2015 (Actual)
- Completion
- Feb 2015 (Actual)
- Last update posted
- Nov 9, 2021
2014 – 2015
United States locations
- U.S. sites
- 51
- U.S. states
- 21
- U.S. cities
- 48
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Teva Investigational Site 12496 | Birmingham | Alabama | — | — |
| Teva Investigational Site 12500 | Mobile | Alabama | — | — |
| Teva Investigational Site 12481 | Little Rock | Alaska | — | — |
| Teva Investigational Site 12515 | Anaheim | California | — | — |
| Teva Investigational Site 12505 | Costa Mesa | California | — | — |
| Teva Investigational Site 12476 | Huntington Beach | California | — | — |
| Teva Investigational Site 12519 | Los Angeles | California | — | — |
| Teva Investigational Site 12484 | Mission Viejo | California | — | — |
| Teva Investigational Site 12510 | Riverside | California | — | — |
| Teva Investigational Site 12483 | Rolling Hills Estates | California | — | — |
| Teva Investigational Site 12511 | Sacramento | California | — | — |
| Teva Investigational Site 12485 | Stockton | California | — | — |
| Teva Investigational Site 12512 | Centennial | Colorado | — | — |
| Teva Investigational Site 12522 | Gainesville | Florida | — | — |
| Teva Investigational Site 12535 | Hollywood | Florida | — | — |
| Teva Investigational Site 12526 | Miami | Florida | — | — |
| Teva Investigational Site 12516 | Orlando | Florida | — | — |
| Teva Investigational Site 12517 | Tamarac | Florida | — | — |
| Teva Investigational Site 12527 | Vero Beach | Florida | — | — |
| Teva Investigational Site 12513 | Winter Park | Florida | — | — |
| Teva Investigational Site 12486 | Gainesville | Georgia | — | — |
| Teva Investigational Site 12497 | Lawrenceville | Georgia | — | — |
| Teva Investigational Site 12480 | Savannah | Georgia | — | — |
| Teva Investigational Site 12508 | Shiloh | Illinois | — | — |
| Teva Investigational Site 12518 | Iowa City | Iowa | — | — |
| Teva Investigational Site 12523 | Covington | Louisiana | — | — |
| Teva Investigational Site 12495 | Warrensburg | Missouri | — | — |
| Teva Investigational Site 12509 | Northfield | New Jersey | — | — |
| Teva Investigational Site 12524 | Brooklyn | New York | — | — |
| Teva Investigational Site 12473 | Raleigh | North Carolina | — | — |
| Teva Investigational Site 12477 | Cincinnati | Ohio | — | — |
| Teva Investigational Site 12525 | Cleveland | Ohio | — | — |
| Teva Investigational Site 12502 | Middleburg Heights | Ohio | — | — |
| Teva Investigational Site 12478 | Oklahoma City | Oklahoma | — | — |
| Teva Investigational Site 12487 | Oklahoma City | Oklahoma | — | — |
| Teva Investigational Site 12506 | Oklahoma City | Oklahoma | — | — |
| Teva Investigational Site 12492 | Tulsa | Oklahoma | — | — |
| Teva Investigational Site 12507 | Gresham | Oregon | — | — |
| Teva Investigational Site 12501 | Normal Square | Pennsylvania | — | — |
| Teva Investigational Site 12493 | Pittsburgh | Pennsylvania | — | — |
| Teva Investigational Site 12488 | Upland | Pennsylvania | — | — |
| Teva Investigational Site 12514 | Greenville | South Carolina | — | — |
| Teva Investigational Site 12474 | Orangeburg | South Carolina | — | — |
| Teva Investigational Site 12479 | Spartanburg | South Carolina | — | — |
| Teva Investigational Site 12489 | Boerne | Texas | — | — |
| Teva Investigational Site 12475 | Waco | Texas | — | — |
| Teva Investigational Site 12491 | Burke | Virginia | — | — |
| Teva Investigational Site 12504 | Charlottesville | Virginia | — | — |
| Teva Investigational Site 12482 | Richmond | Virginia | — | — |
| Teva Investigational Site 12498 | Richmond | Virginia | — | — |
| Teva Investigational Site 12490 | Spokane | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02126839, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 9, 2021 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02126839 live on ClinicalTrials.gov.